The consumer healthcare industry is experiencing an operational and commercial transformation. Over the counter (OTC) medicines, oral care, and nutritional wellness brands, historically managed as downstream commercial offshoots of research-and-development-driven pharmaceutical conglomerates, are decoupling from corporate biopharmaceutical parents. Operating as independent, market responsive commercial entities, these businesses face fundamentally restructured corporate manda